Lunai Bioworks Inc
(LNAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,486 | -12,158 | -7,700 | -113,433 | -23,196 |
| Depreciation Amortization | 309 | 207 | 103 | 93,674 | 318 |
| Accounts payable and accrued liabilities | 3,070 | 3,153 | 3,281 | 1,081 | 167 |
| Other Working Capital | 3,322 | 3,481 | 3,498 | 1,415 | -223 |
| Other Operating Activity | 272 | -888 | -1,836 | 1,531 | 10,253 |
| Operating Cash Flow | $-9,513 | $-6,205 | $-2,654 | $-15,732 | $-12,682 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -24 | N/A | -5 | -5 |
| Investing Cash Flow | $-24 | $-24 | $N/A | $-5 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,625 | 1,625 | 1,625 | 4,806 | 3,630 |
| Other Financing Activity | 1,642 | -467 | -167 | -556 | -450 |
| Financing Cash Flow | $3,267 | $1,158 | $1,458 | $4,251 | $3,180 |
| Exchange Rate Effect | 46 | 17 | -5 | -5 | -7 |
| Beginning Cash Position | 9,172 | 9,172 | 9,172 | 20,664 | 20,664 |
| End Cash Position | 2,948 | 4,119 | 7,972 | 9,172 | 11,151 |
| Net Cash Flow | $-6,224 | $-5,053 | $-1,200 | $-11,492 | $-9,514 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,513 | -6,205 | -2,654 | -15,732 | -12,682 |
| Capital Expenditure | -24 | -24 | N/A | -5 | -5 |
| Free Cash Flow | -9,537 | -6,229 | -2,654 | -15,738 | -12,687 |